The Pitt — Episode 1-01, ER scene:
An elderly anticoagulated woman is brought to the emergency department with atrial fibrillation and intracranial bleeding. The radiologist assesses: "Intracranial hemorrhage, bleeding in the lateral ventricle." The doctor explains: "She's in A-fib, anticoagulated, and now she's got intracranial bleeding. We need to reverse the anticoagulation fast." The team administers vitamin K and fresh frozen plasma to reverse warfarin.
What is Atrial Fibrillation with Intracranial Hemorrhage?
Atrial fibrillation (AF) is a cardiac arrhythmia in which the atria contract in a disorganized and rapid manner, increasing the risk of thrombosis and stroke. Patients with AF often receive anticoagulants (warfarin, apixaban, rivaroxaban) to prevent stroke. Intracranial hemorrhage is bleeding inside the skull that can be epidural, subdural, subarachnoid, or intraparenchymal. When an anticoagulated patient suffers intracranial hemorrhage, there is a clinical dilemma: continuing anticoagulation increases bleeding, but reversing anticoagulation increases stroke risk. Appropriate management requires careful balance and rapid decisions.
Causes & Clinical Context
Intracranial hemorrhage in anticoagulated patients can be caused by trauma, hypertension, aneurysm, vascular malformation, or excessive anticoagulation. As seen in "The Pitt" Episode 1-01, the elderly patient was in AF and anticoagulated with warfarin, and suffered intracranial hemorrhage. Epidemiology shows that anticoagulated patients have increased risk of intracranial hemorrhage (approximately 0.5-1% per year). Mortality of intracranial hemorrhage in anticoagulated patients is higher than in non-anticoagulated (approximately 50-60% vs 30-40%). Appropriate emergency management is critical to save lives.
Signs & Symptoms
Patients with intracranial hemorrhage may present with symptoms varying depending on location and volume of bleeding. Symptoms include severe headache, vomiting, altered mental status, seizures, focal neurological deficit (weakness, aphasia), and possible coma. Some patients may be unconscious. Signs of increased intracranial pressure include progressive headache, vomiting, altered mental status, bradycardia, and hypertension. Rapid neurological assessment is essential.
Diagnosis
Diagnosis of intracranial hemorrhage is confirmed by non-contrast computed tomography (CT) of the head, which shows blood as hyperdense area. CT can show location (epidural, subdural, subarachnoid, intraparenchymal), volume, and presence of midline shift. Magnetic resonance imaging may be necessary in some cases. Coagulation studies (INR, prothrombin time) should be obtained to assess anticoagulation level. Neurological assessment using the Glasgow Coma Scale is important.
Emergency Treatment
Management of intracranial hemorrhage in anticoagulated patient requires rapid action. First, obtain urgent head CT. Second, reverse anticoagulation: for warfarin, administer vitamin K (10 mg IV slowly) and fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC); for apixaban/rivaroxaban, consider idarucizumab or andexanet alfa if available. Third, monitor vital signs and neurological signs. Fourth, control blood pressure (target SBP less than 140 mmHg). Fifth, neurosurgery consultation if large hematoma or neurological deterioration. Sixth, seizure prevention with phenytoin if indicated.
Prognosis & Complications
Prognosis of intracranial hemorrhage in anticoagulated patient depends on bleeding volume, location, time to treatment, and quality of management. Potential complications include increased bleeding, increased intracranial pressure, neuronal death, seizures, death, and permanent neurological sequelae. Mortality rate is approximately 50-60%. Many survivors have permanent disability. Long-term neurological rehabilitation is often necessary.
Frequently Asked Questions
Q: How to reverse warfarin in intracranial hemorrhage?
A: Administer vitamin K (10 mg IV slowly) and fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC). Vitamin K takes 12-24 hours to take effect, so FFP/PCC is necessary to reverse rapidly.
Q: What is the risk of stroke when reversing anticoagulation in intracranial hemorrhage?
A: Risk of stroke increases, but is acceptable in context of active intracranial hemorrhage. Reintroduction of anticoagulation should be considered after stabilization.
Q: What is the role of neurosurgery in intracranial hemorrhage?
A: Neurosurgery may be necessary to drain hematoma if large or causing compression of vital structures. Decision depends on size, location, and neurological deterioration.
Q: When to reintroduce anticoagulation after intracranial hemorrhage?
A: Decision is complex and depends on type of AF (valvular vs non-valvular), severity of hemorrhage, and stroke risk. Generally, wait 7-14 days before reintroducing.
Conclusion
Intracranial hemorrhage in anticoagulated patient is an emergency requiring rapid recognition and aggressive management to save lives. As seen in "The Pitt" Episode 1-01, the ER team responded appropriately with urgent CT and anticoagulation reversal. Understanding its presentation, diagnosis, and management is fundamental for emergency healthcare professionals. For emergencies, call 911 or go to the nearest emergency department. Check out our articles on Atrial Fibrillation, Intracranial Hemorrhage, and Vitamin K for complementary information.
This content is for educational purposes only and does not substitute professional medical advice. Always consult a qualified physician for diagnosis and treatment of any medical condition.
